Hongyu Wang1, Sen Su1, Chao Wang2, Jianhong Hu2, Wu Dan1, Xi Peng1. 1. Clinical Medical Research Center, Southwest Hospital, The Third Military Medical University, Chongqing 400000, China. 2. Institute of Burn Research, Southwest Hospital, State Key Laboratory of Trauma, Burns and Combined Injury, The Third Military Medical University, Chongqing, China.
Abstract
Background: Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. Although fish oil has been used as an immunonutritional preparations for the treatment of sepsis patients, there is still controversy as to whether it is beneficial to them. We systematically reviewed published clinical trial data to evaluate the effectiveness of fish oil-containing nutrition supplementation in sepsis patients. Methods: A systematic search was undertaken in PubMed, Embase, Chinese Biomedicine Database, the Cochrane Library and the China Knowledge Resource Integrated Database to obtain clinical controlled trails. RCTs on nutrition therapy containing fish oil among adult sepsis patients were selected for analysis in comparison with routine therapy. Results: Twenty-five published trials were included in the meta-analysis. Fish oil-containing nutrition supplementation reduced the mortality compared with the control group (relative risk (RR) 0.74, I 2 = 0%). Fish oil also shortened the ICU stay (MD -3.57 days; 95% CI -4.54, -2.59; p<0.00001; I 2 = 76%), hospital stay (MD -9.92 days; 95% CI -15.37, -4.46; p = 0.0004; I 2 = 91%) and the duration of mechanical ventilation support (MD -2.26; 95% CI -4.27, -0.26; p = 0.03; I 2 = 83%). A subgroup analysis based on the route of administration revealed that parenteral administration of fish oil could reduce mortality in septic patients (RR =0.68, I 2 = 0%), but no significant difference in mortality was observed in the fish oil group administered by enteral route (RR = 0.80, I 2 = 0%). No statistically significant publication biases were detected for the above clinical endpoints (p>0.05). Conclusions: Parenteral nutrition containing fish oil could significantly decrease mortality in sepsis patients while enteral administration could not. Fish oil-containing nutrition supplementation.
Background: Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. Although fish oil has been used as an immunonutritional preparations for the treatment of sepsis patients, there is still controversy as to whether it is beneficial to them. We systematically reviewed published clinical trial data to evaluate the effectiveness of fish oil-containing nutrition supplementation in sepsis patients. Methods: A systematic search was undertaken in PubMed, Embase, Chinese Biomedicine Database, the Cochrane Library and the China Knowledge Resource Integrated Database to obtain clinical controlled trails. RCTs on nutrition therapy containing fish oil among adult sepsis patients were selected for analysis in comparison with routine therapy. Results: Twenty-five published trials were included in the meta-analysis. Fish oil-containing nutrition supplementation reduced the mortality compared with the control group (relative risk (RR) 0.74, I 2 = 0%). Fish oil also shortened the ICU stay (MD -3.57 days; 95% CI -4.54, -2.59; p<0.00001; I 2 = 76%), hospital stay (MD -9.92 days; 95% CI -15.37, -4.46; p = 0.0004; I 2 = 91%) and the duration of mechanical ventilation support (MD -2.26; 95% CI -4.27, -0.26; p = 0.03; I 2 = 83%). A subgroup analysis based on the route of administration revealed that parenteral administration of fish oil could reduce mortality in septic patients (RR =0.68, I 2 = 0%), but no significant difference in mortality was observed in the fish oil group administered by enteral route (RR = 0.80, I 2 = 0%). No statistically significant publication biases were detected for the above clinical endpoints (p>0.05). Conclusions: Parenteral nutrition containing fish oil could significantly decrease mortality in sepsis patients while enteral administration could not. Fish oil-containing nutrition supplementation.
Authors: Emilie Mas; Anne Barden; Valerie Burke; Lawrence J Beilin; Gerald F Watts; Rae-Chi Huang; Ian B Puddey; Ashley B Irish; Trevor A Mori Journal: Clin Nutr Date: 2015-04-13 Impact factor: 7.324
Authors: Ignacio Rubio; Marcin F Osuchowski; Manu Shankar-Hari; Tomasz Skirecki; Martin Sebastian Winkler; Gunnar Lachmann; Paul La Rosée; Guillaume Monneret; Fabienne Venet; Michael Bauer; Frank M Brunkhorst; Matthijs Kox; Jean-Marc Cavaillon; Florian Uhle; Markus A Weigand; Stefanie B Flohé; W Joost Wiersinga; Marta Martin-Fernandez; Raquel Almansa; Ignacio Martin-Loeches; Antoni Torres; Evangelos J Giamarellos-Bourboulis; Massimo Girardis; Andrea Cossarizza; Mihai G Netea; Tom van der Poll; André Scherag; Christian Meisel; Joerg C Schefold; Jesús F Bermejo-Martín Journal: Lancet Infect Dis Date: 2019-10-17 Impact factor: 25.071
Authors: Louise Bowman; Marion Mafham; Karl Wallendszus; Will Stevens; Georgina Buck; Jill Barton; Kevin Murphy; Theingi Aung; Richard Haynes; Jolyon Cox; Aleksandra Murawska; Allen Young; Michael Lay; Fang Chen; Emily Sammons; Emma Waters; Amanda Adler; Jonathan Bodansky; Andrew Farmer; Roger McPherson; Andrew Neil; David Simpson; Richard Peto; Colin Baigent; Rory Collins; Sarah Parish; Jane Armitage Journal: N Engl J Med Date: 2018-08-26 Impact factor: 91.245
Authors: Stephen J Nicholls; A Michael Lincoff; Michelle Garcia; Dianna Bash; Christie M Ballantyne; Philip J Barter; Michael H Davidson; John J P Kastelein; Wolfgang Koenig; Darren K McGuire; Dariush Mozaffarian; Paul M Ridker; Kausik K Ray; Brian G Katona; Anders Himmelmann; Larrye E Loss; Martin Rensfeldt; Torbjörn Lundström; Rahul Agrawal; Venu Menon; Kathy Wolski; Steven E Nissen Journal: JAMA Date: 2020-12-08 Impact factor: 56.272